MFS
IRD

Miller Financial Services’s Opus Genetics IRD Stock Holding History

Miller Financial Services’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
27,000
+5,000
+23% +$23.3K 0.09% 134
2026
Q1 		$100K Buy
22,000
+12,000
+120% +$41.5K 0.11% 112
2025
Q4 		$20.1K Buy
+10,000
New +$20.3K 0.02% 113

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Miller Financial Services's IRD Position: Q2 2026 in Review

Miller Financial Services increased its Opus Genetics (IRD) stake by 23% in Q2 2026, buying an estimated $23.3K and bringing the position to 27,000 shares worth $111K. The position accounts for 0.09% of the portfolio, ranked #134.

Miller Financial Services first reported a position in IRD in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Miller Financial Services held 27,000 shares of Opus Genetics worth $111K as of Q2 2026.
  • Miller Financial Services bought 5,000 Opus Genetics shares in Q2 2026, an estimated $23.3K.
  • Opus Genetics made up 0.09% of Miller Financial Services's portfolio in Q2 2026, its #134 holding.
  • Miller Financial Services first reported a position in Opus Genetics in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.